CClinicalTrials.gg
WithdrawnNCT04915885Updated May 17, 2024

Strengthening Contraceptive Counseling in Pakistan

An interventional study of Routine care and Package of contraceptive counseling interventions in Contraception, sponsored by Nguyen-Toan Tran. Withdrawn. Open to female participants aged 15 Years to 49 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-05-17.

Sponsored by Nguyen-Toan Tran · Not applicable, Interventional, and Health services research

Why this study was withdrawn
Additional country (Nigeria) has been added to original country, Pakistan. Therefore, an updated protocol has been submitted (NCT06081842)
Phase
Not applicable
Study type
Interventional
Enrollment
0
Allocation
Randomized
Ages
15 Years to 49 Years
Sex
Female
01

Study summary

High-quality contraceptive counseling can strengthen global efforts to reduce the unmet need for and suboptimal use of modern contraceptives. This study aims to identify a package of contraceptive counseling interventions designed to strengthen existing contraceptive services and determine its effectiveness in increasing clients' level of decision-making autonomy and meeting their contraceptive needs.

Read the detailed description

Methods The five-phase complex intervention design starts with a pre-formative phase aimed at mapping potential study sites to establish the sampling frame. The two-part formative phase first uses participatory approaches to identify the perspectives of clients, including young people and providers, to ensure research contextualization and address each interest group's needs and priorities; clinical observations of client-provider encounters to document routine care form the second part. The design workshop of the third phase will result in the development of a package of contraceptive counseling interventions. In the fourth and experimental phase, a multi-intervention, three-arm, single-blinded, parallel cluster randomized-controlled trial will compare routine care (arm 1) with the contraceptive counseling package (arm 2) and the same package combined with wider method availability (arm 3). The fifth and reflective phase aims to analyze the package's cost-effectiveness and identify implementation barriers and enablers. The primary outcomes are clients' level of decision-making autonomy and met need for modern contraceptives.

Discussion Applying participatory action research principles in designing, testing, and scaling up effective, affordable, and sustainable counseling interventions could help optimize clients' decision-making autonomy and meet their needs for modern contraceptives in low-resource settings. Recognizing the socio-cultural and health service complexities surrounding contraception, including client-provider power dynamics, the study assumes that engaging key stakeholders, including adolescents, women, men, service providers, and policymakers would be more effective. A set of low-technology interventions will likely affect, at the individual level and in a sustainable way, the knowledge, attitudes, and behaviors of women and couples toward contraceptive counseling and provision. At the health service delivery level, the trial implementation would necessitate a shift in providers' attitudes and accountability toward a systematic integration into their clinical practice of must-have and person-centered counseling components, as well as improved health service organization to ensure the availability of competent staff and diversity of contraceptive choices.

02

Conditions studied

  • Contraception

Keywords

  • Counseling
  • Empowerment
  • Autonomy
03

In context

Lead sponsor

This is the only study on the registry with Nguyen-Toan Tran as lead sponsor.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
15 Years to 49 Years
Sexes eligible
Female
Accepts healthy volunteers
Yes

Eligibility criteria

  1. she comes to the family planning clinic with the intention to 1.a. use contraception for the first time in her life (new user), or 1.b. switch from a contraceptive method to another one (switching user), or 1.c. resume a method after not using any in the prior three months (lapse user), or 1.d. discontinue a modern method (discontinuing user);
  2. she is not coming for the resupply of a currently used method, such as pills or injectables;
  3. she has the intention to continue her follow-up at the health center during the 12-month study follow-up;
  4. she does not participate in another study; and
  5. she provides informed consent.
05

Study design

Phase
Not applicable
Primary purpose
Health services research
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
0 participants (actual)

Study arms

  • Other
    Control arm

    routine contraceptive counseling and care and a range of family planning methods that are routinely available at field level

    Other: Routine care

  • Experimental
    Intervention package

    contraceptive counseling package but still with a range of family planning methods that are routinely available at field level

    Other: Package of contraceptive counseling interventions

  • Experimental
    Intervention package & expanded methods

    contraceptive counseling package but with an expanded range of family planning methods that are recommended by national guidance

    Other: Package of contraceptive counseling interventions · Other: Expanded methods

Interventions

  • OtherRoutine care

    Routine contraceptive counseling and routine method availability

  • OtherPackage of contraceptive counseling interventions

    The implementation package will be co-designed by providers and clients during the formative and research design phases

  • OtherExpanded methods

    Expanded range of contraceptive methods as recommended by national policies

06

What researchers measure

Primary outcomes

  1. Change in clients' decision-making autonomy

    Person-Centered Contraceptive Counseling scale (PCCC), developed and tested by Dehlendorf et al. (2021)

    Time frame: Through study completion, an average of 1 year

  2. Change in clients' met need for family planning

    number of participants who want to avoid a pregnancy and are using a contraceptive method / all participants

    Time frame: Through study completion, an average of 1 year

Secondary outcomes

  1. Change in modern contraceptive prevalence

    number of participants using a modern contraceptive / all participants

    Time frame: 6 months and 12 months post enrollment

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: Yes — (i) use of a controlled access approach, such as upon reasonable request from the World Health Organization; (ii) the trial will seek consent for sharing IPD from trial participants with adequate assurance that patient privacy and confidentiality will be maintained

Supporting information: Study protocol, Sap, Icf, Csr, Analytic code

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 17, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04915885
Lead sponsor
Nguyen-Toan Tran
Responsible party
Nguyen-Toan Tran (World Health Organization consultant, University of Geneva, Switzerland) — Sponsor-investigator
First posted
Jun 7, 2021
Start date
Jan 2022 (estimated)
Primary completion
Dec 2024 (estimated)
Completion
Dec 2025 (estimated)
Last update
May 17, 2024

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is withdrawn, as verified in May 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion